Rigel Pharmaceuticals Inc
RIGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001034842
No open-market purchases or sales by Rigel Pharmaceuticals Inc insiders were filed in the last 90 days; 155 institutions reported holding it in 13F filings for Q2 2026, worth $640.4M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Rigel Pharmaceuticals Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 135 | 138 | +3 |
| Shares | 139.2M | 127.9M | −11.3M (−8.1%) |
| Value | $157.2M | $150.3M | −$6.91M (−4.4%) |
New holders (21)
Institutions that held Rigel Pharmaceuticals Inc at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (18)
Institutions that held Rigel Pharmaceuticals Inc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Candriam Luxembourg S.C.A. | 1,429,630 | $1.61M |
| Rafferty Asset Management, LLC | 1,088,543 | $1.23M |
| Woodline Partners LP | 861,305 | $973.0K |
| Ikarian Capital, LLC | 702,773 | $794.0K |
| Adage Capital Partners GP, L.L.C. | 700,000 | $791.0K |
| UBS Group AG | 590,858 | $668.0K |
| DAFNA Capital Management LLC | 390,066 | $441.0K |
| Caption Management, LLC | 345,300 | $390.0K |
| Dimensional Fund Advisors LP | 287,685 | $325.0K |
| Virtu Financial LLC | 245,227 | $277.0K |
| First Hawaiian Bank | 163,484 | $185.0K |
| E Fund Management Co., Ltd. | 124,818 | $141.0K |
| Boothbay Fund Management, LLC | 96,883 | $109.0K |
| Oppenheimer & Co Inc | 42,587 | $48.0K |
| Two Sigma Securities, LLC | 36,466 | $41.0K |
| State of Wyoming | 7,975 | $9.00K |
| Captrust Financial Advisors | 1,084 | $1.00K |
| Aquatic Capital Management LLC | 1,200 | $1.00K |